Ratings by Citi
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 9/1/2026 | Paul Lejuez | Kroger | KR | Maintain | Neutral (N/A) |
57.00 (61.00) |
|
Details | |
| 9/1/2026 | Geoff Meacham | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
182.00 (175.00) |
|
Details | |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 29,976 more... | |||||||||
